Local News Athira Pharma Announces Completion of Enrollment in Phase II ACT-AD Trial Evaluating ATH-1017 for Mild-to-Moderate Alzheimer’s Disease Athira Pharma | October 28, 2021 Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore…dcorriganOctober 28, 2021 Read More
Local News Mozart Therapeutics Launches with $55 Million Series a Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases Mozart Therapeutics | October 28, 2021 Mozart Therapeutics, Inc., a new biopharmaceutical company targeting a novel immune pathway to change the…dcorriganOctober 28, 2021 Read More
Local News Looking Back and Projecting Ahead as AVE Celebrates One Year Brotman Baty Institute | October 27, 2021 This October marks the one-year anniversary of the Atlas of Variant Effects (AVE) Alliance. AVE…dcorriganOctober 27, 2021 Read More
Local News How Pandemic-Driven Talent Migration Will Change Where Biotech Companies Are Located GeekWire | October 27, 2021 Joel Marcus’ fortunes have risen with those of the life sciences industry. The executive chairman…dcorriganOctober 27, 2021 Read More
Local News Antibiotics for Appendicitis: Study Findings Finalized UW Medicine | October 27, 2021 Antibiotics are now an accepted first-line treatment for most people with appendicitis, according to final…dcorriganOctober 27, 2021 Read More
Local News Nudging Cells to Repair Damaged Retinas UW Medicine | October 25, 2021 In an approach could someday be used to help repair the retinas in patients who…dcorriganOctober 25, 2021 Read More
Local News NIH Supports Studies on Senescent Cells UW Medicine | October 25, 2021 Efforts to understand aging cells in human tissues have received increased support from the National…dcorriganOctober 25, 2021 Read More
Local News Seal Rock Therapeutics Announces Completion of Single Ascending Dose Cohort in Phase I Clinical Trial of ASK1 Inhibitor SRT-015 for NASH Seal Rock Therapeutics | October 21, 2021 Seal Rock Therapeutics, Inc., a clinical-stage biotechnology company developing a platform of first-in-class and best-in-class therapeutic…dcorriganOctober 21, 2021 Read More
Local News Cell Therapy Startup Immusoft Lands Deal with Takeda Worth Potentially More than $900M GeekWire | October 20, 2021 Seattle-based cell therapy startup Immusoft will collaborate with pharma giant Takeda to develop treatments targeted…dcorriganOctober 20, 2021 Read More
Local News Faraday Pharmaceuticals Announces First Patient Enrolled in Phase II Study for ICU-Acquired Weakness Faraday Pharmaceuticals | October 19, 2021 Faraday Pharmaceuticals, Inc., a biopharmaceutical company dedicated to improving the quality of life for patients…dcorriganOctober 19, 2021 Read More